GBA Presents: THE GREEN MARKET
- Thread starter stonedinvestor
- Start date
That is NOT Michael. But I like the moves.
I've loved this little company for along time. Never owned it yet.
Screw Mexico I told my wife no way! She waned to go on a Yoga retreat ha ha ha get kidnapped and shit. I told her wait for Majorca... of course she then said oh goodie that one is coming. 
I just tried one of those virtual health sites it did not go well/ It's actually a portal with my own Dr's office so I don't know why they freaked out on me.
Virtual Health: How may we assist you
stonedinvestor: I have a situation I think it may be an ingrown hair.
Virtual Health: Ok great we would like to help you. Where is the problem.
stonedinvestor: RIGHT HERE!
Virtual Health: Our session is now closed. If you would like to contact VH again please first take a picture of yourself wearing a mask.
I just tried one of those virtual health sites it did not go well/ It's actually a portal with my own Dr's office so I don't know why they freaked out on me.
Virtual Health: How may we assist you
stonedinvestor: I have a situation I think it may be an ingrown hair.
Virtual Health: Ok great we would like to help you. Where is the problem.
stonedinvestor: RIGHT HERE!
Virtual Health: Our session is now closed. If you would like to contact VH again please first take a picture of yourself wearing a mask.
BIO-key signs definitive agreement to acquire Swivel Secure Europe 08:09 BKYI BIO-key International announced that it has signed a definitive agreement to acquire Swivel Secure Europe, SSE, a privately-held IAM solutions provider based in Spain. The transaction is expected to close in February and be accretive to BIO-key's earnings, excluding one-time acquisition-related costs and ongoing purchase accounting amortization expenses. As a result of the acquisition, BIO-key will add a sales and support team with customer and industry contacts throughout the EMEA region. Alex Rocha, SSE's sole stockholder and Chief Executive Officer, will also assume responsibility for EMEA operations reporting directly to BIO-key's Chairman & CEO. "Swivel Secure Europe and its talented team have established a deep network of partners and customers across Europe, the Middle East and Africa, and this acquisition significantly strengthens BIO-key's presence in those regions," said BIO-key Chairman & CEO Michael DePasquale. "We are seeing cyber attacks and threats grow in sophistication and scale and as a result, demand for proven IAM solutions continues to grow. We look forward to expanding our global sales footprint and to supporting Swivel Secure Europe's customers and partners through an award-winning and cost-effective portfolio of existing and new IAM and identity-bound biometric solutions."
Azek sees FY22 onsolidated Net Sales Growth of 17% to 21% YoY, consensus $1.38B 07:50 AZEK
Azek reports Q1 EPS 18c, consensus 16c 07:49 AZEK Reports Q1 revenue $259.7M, consensus $257.13M.
Biohaven Pharmaceutical's Nurtec shows migraine reduction in published report 07:43 BHVN
Berry Global backs FY22 adjusted EPS $7.20-$7.70, consensus $7.40 07:40 BERY Sees FY22 free cash flow $900M-$1B. Salmon added, "We are pleased with the efforts of our teams and resilience of our business to reaffirm guidance given persistent inflation, supply chain disruptions, and labor constraints. We expect supply chains to improve and inflation to moderate as the year progresses. As referenced on our last call, we remain committed to recovering the significant cost inflation we witnessed in fiscal 2021, and in early fiscal 2022. We anticipate, from both an earnings and volume perspective, a stronger second half of the fiscal year as we continue to recover inflation, experience supply chain improvements and see new business and capital investments ramp up."
Morgan Stanley buyers of dip in Sonos with stock 43% off 52-week high 07:37 SONO Morgan Stanley analyst Katy Huberty lowered the firm's price target on Sonos to $45 from $49, but keeps an Overweight rating on the shares and recommends that investors take "advantage of an asymmetrically skewed positive risk/reward" she now sees with the stock 43% off its 52-week high of $45 in spite of the fact that consensus FY22 EBITDA has been revised 48% higher over the last 12 months. The stock has underperformed peers due to concerns of COVID pull-forward and a below seasonal December quarter as the market appears to be pricing in a greater than 15% cut to FY22 EBITDA, while undervaluing the long term durability of its ecosystem, Huberty tells investors.
Azek reports Q1 EPS 18c, consensus 16c 07:49 AZEK Reports Q1 revenue $259.7M, consensus $257.13M.
Biohaven Pharmaceutical's Nurtec shows migraine reduction in published report 07:43 BHVN
Berry Global backs FY22 adjusted EPS $7.20-$7.70, consensus $7.40 07:40 BERY Sees FY22 free cash flow $900M-$1B. Salmon added, "We are pleased with the efforts of our teams and resilience of our business to reaffirm guidance given persistent inflation, supply chain disruptions, and labor constraints. We expect supply chains to improve and inflation to moderate as the year progresses. As referenced on our last call, we remain committed to recovering the significant cost inflation we witnessed in fiscal 2021, and in early fiscal 2022. We anticipate, from both an earnings and volume perspective, a stronger second half of the fiscal year as we continue to recover inflation, experience supply chain improvements and see new business and capital investments ramp up."
Morgan Stanley buyers of dip in Sonos with stock 43% off 52-week high 07:37 SONO Morgan Stanley analyst Katy Huberty lowered the firm's price target on Sonos to $45 from $49, but keeps an Overweight rating on the shares and recommends that investors take "advantage of an asymmetrically skewed positive risk/reward" she now sees with the stock 43% off its 52-week high of $45 in spite of the fact that consensus FY22 EBITDA has been revised 48% higher over the last 12 months. The stock has underperformed peers due to concerns of COVID pull-forward and a below seasonal December quarter as the market appears to be pricing in a greater than 15% cut to FY22 EBITDA, while undervaluing the long term durability of its ecosystem, Huberty tells investors.
IDea #1 Been Here before.
The AZEK Company Inc. (AZEK)
NYSE - NYSE Delayed Price. Currency in USD
34.68+0.20(+0.58%)
At close: February 2 04:00PM EST
36.00+1.32(+3.81%)
Pre-Market:08:46AM EST
IDea #2 Can't figure out when they report...
Shift4 Payments, Inc. (FOUR)
NYSE - NYSE Delayed Price. Currency in USD
51.51-1.31(-2.48%)
At close: February 2 04:00PM EST
49.99-1.52(-2.95%)
Pre-Market:08:16AM EST
1/31 MACD turned up
Had made a low at $45 then Three Green bars...
now met by red visa vi PYPL.....
The AZEK Company Inc. (AZEK)
NYSE - NYSE Delayed Price. Currency in USD
34.68+0.20(+0.58%)
At close: February 2 04:00PM EST
36.00+1.32(+3.81%)
Pre-Market:08:46AM EST
IDea #2 Can't figure out when they report...
Shift4 Payments, Inc. (FOUR)
NYSE - NYSE Delayed Price. Currency in USD
51.51-1.31(-2.48%)
At close: February 2 04:00PM EST
49.99-1.52(-2.95%)
Pre-Market:08:16AM EST
1/31 MACD turned up
Had made a low at $45 then Three Green bars...
now met by red visa vi PYPL.....